Brachytherapy

An overview for clinicians

Cyrus Chargari, Eric Deutsch, Pierre Blanchard, Sebastien Gouy, Hélène Martelli, Florent Guérin, Isabelle Dumas, Alberto Bossi, Philippe Morice, Akila Viswanathan, Christine Haie-Meder

Research output: Contribution to journalReview article

Abstract

Brachytherapy is a specific form of radiotherapy consisting of the precise placement of radioactive sources directly into or next to the tumor. This technique is indicated for patients affected by various types of cancers. It is an optimal tool for delivering very high doses to the tumor focally while minimizing the probability of normal tissue complications. Physicians from a wide range of specialties may be involved in either the referral to or the placement of brachytherapy. Many patients require brachytherapy as either primary treatment or as part of their oncologic care. On the basis of high-level evidence from randomized controlled trials, brachytherapy is mainly indicated: 1) as standard in combination with chemoradiation in patients with locally advanced cervical cancer; 2) in surgically treated patients with uterine endometrial cancer for decreasing the risk of vaginal vault recurrence; 3) in patients with high-risk prostate cancer to perform dose escalation and improve progression-free survival; and 4) in patients with breast cancer as adjuvant, accelerated partial breast irradiation or to boost the tumor bed. In this review, the authors discuss the clinical relevance of brachytherapy with a focus on indications, levels of evidence, and results in the overall context of radiation use for patients with cancer.

Original languageEnglish (US)
Pages (from-to)386-401
Number of pages16
JournalCA Cancer Journal for Clinicians
Volume69
Issue number5
DOIs
StatePublished - Sep 1 2019

Fingerprint

Brachytherapy
Neoplasms
Uterine Neoplasms
Endometrial Neoplasms
Uterine Cervical Neoplasms
Disease-Free Survival
Prostatic Neoplasms
Breast
Radiotherapy
Referral and Consultation
Randomized Controlled Trials
Radiation
Breast Neoplasms
Physicians
Recurrence

Keywords

  • brachytherapy
  • cervical cancer
  • evidence-based medicine
  • image-guided adaptive brachytherapy
  • overall survival
  • precision medicine
  • prostate cancer
  • quality of life
  • radiation oncology
  • therapeutic index

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this

Chargari, C., Deutsch, E., Blanchard, P., Gouy, S., Martelli, H., Guérin, F., ... Haie-Meder, C. (2019). Brachytherapy: An overview for clinicians. CA Cancer Journal for Clinicians, 69(5), 386-401. https://doi.org/10.3322/caac.21578

Brachytherapy : An overview for clinicians. / Chargari, Cyrus; Deutsch, Eric; Blanchard, Pierre; Gouy, Sebastien; Martelli, Hélène; Guérin, Florent; Dumas, Isabelle; Bossi, Alberto; Morice, Philippe; Viswanathan, Akila; Haie-Meder, Christine.

In: CA Cancer Journal for Clinicians, Vol. 69, No. 5, 01.09.2019, p. 386-401.

Research output: Contribution to journalReview article

Chargari, C, Deutsch, E, Blanchard, P, Gouy, S, Martelli, H, Guérin, F, Dumas, I, Bossi, A, Morice, P, Viswanathan, A & Haie-Meder, C 2019, 'Brachytherapy: An overview for clinicians', CA Cancer Journal for Clinicians, vol. 69, no. 5, pp. 386-401. https://doi.org/10.3322/caac.21578
Chargari C, Deutsch E, Blanchard P, Gouy S, Martelli H, Guérin F et al. Brachytherapy: An overview for clinicians. CA Cancer Journal for Clinicians. 2019 Sep 1;69(5):386-401. https://doi.org/10.3322/caac.21578
Chargari, Cyrus ; Deutsch, Eric ; Blanchard, Pierre ; Gouy, Sebastien ; Martelli, Hélène ; Guérin, Florent ; Dumas, Isabelle ; Bossi, Alberto ; Morice, Philippe ; Viswanathan, Akila ; Haie-Meder, Christine. / Brachytherapy : An overview for clinicians. In: CA Cancer Journal for Clinicians. 2019 ; Vol. 69, No. 5. pp. 386-401.
@article{3ffd9416471d42b786f68542e1ca6ee4,
title = "Brachytherapy: An overview for clinicians",
abstract = "Brachytherapy is a specific form of radiotherapy consisting of the precise placement of radioactive sources directly into or next to the tumor. This technique is indicated for patients affected by various types of cancers. It is an optimal tool for delivering very high doses to the tumor focally while minimizing the probability of normal tissue complications. Physicians from a wide range of specialties may be involved in either the referral to or the placement of brachytherapy. Many patients require brachytherapy as either primary treatment or as part of their oncologic care. On the basis of high-level evidence from randomized controlled trials, brachytherapy is mainly indicated: 1) as standard in combination with chemoradiation in patients with locally advanced cervical cancer; 2) in surgically treated patients with uterine endometrial cancer for decreasing the risk of vaginal vault recurrence; 3) in patients with high-risk prostate cancer to perform dose escalation and improve progression-free survival; and 4) in patients with breast cancer as adjuvant, accelerated partial breast irradiation or to boost the tumor bed. In this review, the authors discuss the clinical relevance of brachytherapy with a focus on indications, levels of evidence, and results in the overall context of radiation use for patients with cancer.",
keywords = "brachytherapy, cervical cancer, evidence-based medicine, image-guided adaptive brachytherapy, overall survival, precision medicine, prostate cancer, quality of life, radiation oncology, therapeutic index",
author = "Cyrus Chargari and Eric Deutsch and Pierre Blanchard and Sebastien Gouy and H{\'e}l{\`e}ne Martelli and Florent Gu{\'e}rin and Isabelle Dumas and Alberto Bossi and Philippe Morice and Akila Viswanathan and Christine Haie-Meder",
year = "2019",
month = "9",
day = "1",
doi = "10.3322/caac.21578",
language = "English (US)",
volume = "69",
pages = "386--401",
journal = "Ca-A Cancer Journal for Clinicians",
issn = "0007-9235",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Brachytherapy

T2 - An overview for clinicians

AU - Chargari, Cyrus

AU - Deutsch, Eric

AU - Blanchard, Pierre

AU - Gouy, Sebastien

AU - Martelli, Hélène

AU - Guérin, Florent

AU - Dumas, Isabelle

AU - Bossi, Alberto

AU - Morice, Philippe

AU - Viswanathan, Akila

AU - Haie-Meder, Christine

PY - 2019/9/1

Y1 - 2019/9/1

N2 - Brachytherapy is a specific form of radiotherapy consisting of the precise placement of radioactive sources directly into or next to the tumor. This technique is indicated for patients affected by various types of cancers. It is an optimal tool for delivering very high doses to the tumor focally while minimizing the probability of normal tissue complications. Physicians from a wide range of specialties may be involved in either the referral to or the placement of brachytherapy. Many patients require brachytherapy as either primary treatment or as part of their oncologic care. On the basis of high-level evidence from randomized controlled trials, brachytherapy is mainly indicated: 1) as standard in combination with chemoradiation in patients with locally advanced cervical cancer; 2) in surgically treated patients with uterine endometrial cancer for decreasing the risk of vaginal vault recurrence; 3) in patients with high-risk prostate cancer to perform dose escalation and improve progression-free survival; and 4) in patients with breast cancer as adjuvant, accelerated partial breast irradiation or to boost the tumor bed. In this review, the authors discuss the clinical relevance of brachytherapy with a focus on indications, levels of evidence, and results in the overall context of radiation use for patients with cancer.

AB - Brachytherapy is a specific form of radiotherapy consisting of the precise placement of radioactive sources directly into or next to the tumor. This technique is indicated for patients affected by various types of cancers. It is an optimal tool for delivering very high doses to the tumor focally while minimizing the probability of normal tissue complications. Physicians from a wide range of specialties may be involved in either the referral to or the placement of brachytherapy. Many patients require brachytherapy as either primary treatment or as part of their oncologic care. On the basis of high-level evidence from randomized controlled trials, brachytherapy is mainly indicated: 1) as standard in combination with chemoradiation in patients with locally advanced cervical cancer; 2) in surgically treated patients with uterine endometrial cancer for decreasing the risk of vaginal vault recurrence; 3) in patients with high-risk prostate cancer to perform dose escalation and improve progression-free survival; and 4) in patients with breast cancer as adjuvant, accelerated partial breast irradiation or to boost the tumor bed. In this review, the authors discuss the clinical relevance of brachytherapy with a focus on indications, levels of evidence, and results in the overall context of radiation use for patients with cancer.

KW - brachytherapy

KW - cervical cancer

KW - evidence-based medicine

KW - image-guided adaptive brachytherapy

KW - overall survival

KW - precision medicine

KW - prostate cancer

KW - quality of life

KW - radiation oncology

KW - therapeutic index

UR - http://www.scopus.com/inward/record.url?scp=85070189087&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85070189087&partnerID=8YFLogxK

U2 - 10.3322/caac.21578

DO - 10.3322/caac.21578

M3 - Review article

VL - 69

SP - 386

EP - 401

JO - Ca-A Cancer Journal for Clinicians

JF - Ca-A Cancer Journal for Clinicians

SN - 0007-9235

IS - 5

ER -